HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Childhood Rhabdomyosarcoma

Childhood Rhabdomyosarcoma

Childhood rhabdomyosarcoma is a rare type of cancer that forms in the soft tissues of children, commonly in muscles attached to bones. Despite its rarity, it's one of the most common soft tissue sarcomas in children. Research in this area focuses on understanding the genetic mutations driving its development and identifying more effective treatment strategies. Recent advancements in cancer research have led to targeted therapies that aim to inhibit specific molecular pathways involved in tumor growth. Additionally, immunotherapy approaches, harnessing the body's immune system to target cancer cells, show promise in treating childhood rhabdomyosarcoma. Collaborative efforts among researchers worldwide continue to push the boundaries in improving outcomes for children battling this aggressive cancer.

Committee Members
Committee Member - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
Committee Member - Atif A Ahmed

Atif A Ahmed

Seattle Children’s Hospital, United States
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
CIOC 2027 Speakers
Thomas Jay Webster

Thomas Jay Webster

Brown University, United States
Eleni Petsalaki

Eleni Petsalaki

University of Crete, Greece
Saumya Pandey

Saumya Pandey

Indira IVF Hospital, India

Submit your abstract Today

YouTube
WhatsAppWhatsApp